Evaluation of Pharmaceutical Intervention at Hepatitis C Medication Therapy Adherence Clinic in North Borneo, Malaysia (Epic MTAC)

Bee Keng Law; Euginie Tracy Wong; Qiao Wei Liew; Zhi Sam Heng

doi:10.51200/bjms.vi1.2318

Evaluation of Pharmaceutical Intervention at Hepatitis C Medication Therapy Adherence Clinic in North Borneo, Malaysia (Epic MTAC)

Authors

Bee Keng Law Department of Pharmacy, Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia
Euginie Tracy Wong Department of Pharmacy, Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia
Qiao Wei Liew Department of Pharmacy, Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia
Zhi Sam Heng Department of Pharmacy, Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia

DOI:

https://doi.org/10.51200/bjms.vi1.2318

Keywords:

pharmacist, hepatitis C, pharmaceutical intervention, Medication Therapy Adherence Clinic (MTAC), Sustained Virological Response (SVR)

Abstract

Introduction: Hepatitis C virus (HCV) is a worrying public health issue worldwide. The introduction of direct-acting antiviral agents (DAAs) brings revolution to HCV treatment. Pharmacistsâ€™ role in Malaysia is significant since the implementation of Medication Therapy Adherence Clinic (MTAC). This study aims to determine the sustained virological response (SVR12) for HCV patients treated with Sofosbuvir and Daclatasvir and/or Ribavirin. Besides, it evaluates adherence rate, types of pharmaceutical intervention and physiciansâ€™ acceptance rate.

Downloads

4_BJMS_Special Issue_Vol.3_March_2020

Additional Files

4_BJMS_Special Issue_Vol.3_March_2020

Published

2020-03-30

How to Cite

Law, B. K., Wong, E. T., Liew, Q. W., & Heng, Z. S. (2020). Evaluation of Pharmaceutical Intervention at Hepatitis C Medication Therapy Adherence Clinic in North Borneo, Malaysia (Epic MTAC). Borneo Journal of Medical Sciences (BJMS), (1), 9. https://doi.org/10.51200/bjms.vi1.2318

Download Citation

Issue

2020: BORNEO JOURNAL OF MEDICAL SCIENCES (BJMS), (Suppl.), MARCH 2020

Section

Abstracts

License

All articles are published under the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license, enabling users to read, download, copy, distribute, and adapt the material for non-commercial purposes, provided proper credit is given to the original authors and the source. This model supports transparency, accessibility, and the global exchange of medical knowledge.